NO820291L - Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Info

Publication number
NO820291L
NO820291L NO820291A NO820291A NO820291L NO 820291 L NO820291 L NO 820291L NO 820291 A NO820291 A NO 820291A NO 820291 A NO820291 A NO 820291A NO 820291 L NO820291 L NO 820291L
Authority
NO
Norway
Prior art keywords
carbon atoms
hydroxy
formula
diamino
acid
Prior art date
Application number
NO820291A
Other languages
English (en)
Norwegian (no)
Inventor
Jeffrey John Barlow
Leslie Harold Smith
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO820291L publication Critical patent/NO820291L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO820291A 1981-02-02 1982-02-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater NO820291L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8103131 1981-02-02

Publications (1)

Publication Number Publication Date
NO820291L true NO820291L (no) 1982-08-03

Family

ID=10519390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820291A NO820291L (no) 1981-02-02 1982-02-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater

Country Status (21)

Country Link
US (1) US4399138A (de)
EP (1) EP0057572B1 (de)
JP (1) JPS57163370A (de)
KR (1) KR830009069A (de)
AT (1) ATE14576T1 (de)
AU (1) AU550763B2 (de)
CA (1) CA1198110A (de)
DE (1) DE3264964D1 (de)
DK (1) DK43382A (de)
ES (1) ES8304952A1 (de)
FI (1) FI820266L (de)
GR (1) GR75872B (de)
HU (1) HU187634B (de)
IE (1) IE52345B1 (de)
IL (1) IL64890A (de)
NO (1) NO820291L (de)
NZ (1) NZ199627A (de)
PH (1) PH18070A (de)
PT (1) PT74373B (de)
YU (1) YU22082A (de)
ZA (1) ZA82562B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3361244D1 (de) * 1982-01-29 1986-01-02 Ici Plc Alkanolamine derivatives
US4604394A (en) * 1984-10-01 1986-08-05 Merck & Co., Inc. Antiarrhythmic compositions and method
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
US4803206A (en) * 1988-03-07 1989-02-07 Schering Corporation Antihypertensive acylpyrazines
GB8812342D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Bicyclic compounds
GB8812343D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Amino compounds
UY36034A (es) 2014-03-18 2015-09-30 Astrazeneca Ab Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472847A (en) * 1966-08-25 1969-10-14 Merck & Co Inc Conversion of pyrazinoylcyanamides to pyrazinoylguanidines
US3577418A (en) * 1969-02-12 1971-05-04 Merck & Co Inc Pyrazinamide derivatives and processes for their preparation
US3573306A (en) * 1969-03-05 1971-03-30 Merck & Co Inc Process for preparation of n-substituted 3,5-diamino-6-halopyrazinamides
US3544568A (en) * 1969-03-18 1970-12-01 Merck & Co Inc 3-amino-5,6-substituted pyrazinamides
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
US3948895A (en) * 1971-09-28 1976-04-06 E. I. Du Pont De Nemours And Company Synthesis of 3,5-diaminopyrazinoic acid from 3,5-diamino-2,6-dicyanopyrazine and intermediates
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4139623A (en) * 1974-05-14 1979-02-13 C-G Corp. Cyclic-substituted derivatives of 1-amino-2-propanol
US4115409A (en) * 1975-12-05 1978-09-19 Imperial Chemical Industries Limited Alkanolamine derivatives
US4085211A (en) * 1975-12-15 1978-04-18 Merck & Co., Inc. Pyrazinecarboxamides and processes for preparing same
GB1540463A (en) * 1976-10-07 1979-02-14 Ici Ltd Alkanolamine derivatives
US4219561A (en) * 1977-09-22 1980-08-26 Imperial Chemical Industries Limited Alkanolamine derivatives

Also Published As

Publication number Publication date
KR830009069A (ko) 1983-12-17
PH18070A (en) 1985-03-18
ZA82562B (en) 1982-12-29
US4399138A (en) 1983-08-16
AU7994682A (en) 1982-08-12
EP0057572A1 (de) 1982-08-11
GR75872B (de) 1984-08-02
YU22082A (en) 1985-04-30
IL64890A0 (en) 1982-03-31
PT74373B (en) 1983-07-14
IE820175L (en) 1982-08-02
PT74373A (en) 1982-03-01
EP0057572B1 (de) 1985-07-31
ES509250A0 (es) 1983-03-16
IE52345B1 (en) 1987-09-16
FI820266A7 (fi) 1982-08-03
HU187634B (en) 1986-02-28
DE3264964D1 (de) 1985-09-05
JPS57163370A (en) 1982-10-07
AU550763B2 (en) 1986-04-10
CA1198110A (en) 1985-12-17
FI820266L (fi) 1982-08-03
ATE14576T1 (de) 1985-08-15
IL64890A (en) 1986-09-30
ES8304952A1 (es) 1983-03-16
DK43382A (da) 1982-08-03
NZ199627A (en) 1984-11-09

Similar Documents

Publication Publication Date Title
EP0054951B1 (de) Dibenzo(b,f)(1,4)oxazepin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FI88504C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat
EP0506532B1 (de) Indolderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CA2121391A1 (en) Indoloylguanidine derivatives
CZ279774B6 (cs) 3-Aryl-4(3H)-chinazolinonový CCK antagonist a farmaceutický prostředek, který ho obsahuje
Briones et al. Expedient synthesis of tetrahydroquinoline-3-spirohydantoin derivatives via the Lewis acid-catalyzed tert-amino effect reaction
NO820291L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
PT89089B (pt) Processo de preparacao de derivados de alquilaminas substituidas e de composicoes farmaceuticas que os contem
JP4564713B2 (ja) 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
US4314943A (en) Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
FR2537584A1 (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
FR2680172A1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
EP0162776A2 (de) Heterozyklische Derivate, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel brauchbar als Aldosereduktaseinhibitoren
FI85273C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinderivat.
CA1338572C (en) Amino acid esters, process for the preparation thereof and use thereof
US4550111A (en) Alkanolamine derivatives
NO812431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.
JPH06505229A (ja) 抗ウイルス薬としてのチアゾロ−[2,3−a]−イソインドール誘導体の使用および新規なチアゾロ−[2,3−a]−イソインドール誘導体
Miller et al. Anticoccidial derivatives of 6-azauracil. 2. High potency and long plasma life of N1-phenyl structures
EP0668275A1 (de) Pyrrolidinon-Derivate
CA1292739C (en) Heteroaromatic acetylenes useful as antihypertensive agents
US4576954A (en) Anti-rheumatic 5-(substituted amino)-1,2-dithiol-3-one compounds and their use
SU893133A3 (ru) Способ получени производных 1-/3-(3,4,5-триметоксифенокси)-2-пропил/-4-арилпиперазина
JPH02169571A (ja) 置換アリルアミン誘導体
EP1023287B1 (de) 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden